- Home
- GLPG vs MODG Comparison
GLPG vs MODG Comparison
Compare GLPG & MODG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- MODG
- Stock Information
- Founded
- GLPG 1999
- MODG 1982
- Country
- GLPG Belgium
- MODG United States
- Employees
- GLPG N/A
- MODG N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- MODG Recreational Games/Products/Toys
- Sector
- GLPG Health Care
- MODG Consumer Discretionary
- Exchange
- GLPG Nasdaq
- MODG Nasdaq
- Market Cap
- GLPG 2.1B
- MODG 1.9B
- IPO Year
- GLPG 2005
- MODG 1992
- Fundamental
- Price
- GLPG $30.42
- MODG $9.43
- Analyst Decision
- GLPG Hold
- MODG Buy
- Analyst Count
- GLPG 4
- MODG 7
- Target Price
- GLPG $31.33
- MODG $10.93
- AVG Volume (30 Days)
- GLPG 169.3K
- MODG 3.1M
- Earning Date
- GLPG 11-05-2025
- MODG 11-06-2025
- Dividend Yield
- GLPG N/A
- MODG N/A
- EPS Growth
- GLPG N/A
- MODG N/A
- EPS
- GLPG N/A
- MODG N/A
- Revenue
- GLPG $336,643,201.00
- MODG $4,061,200,000.00
- Revenue This Year
- GLPG $1.77
- MODG N/A
- Revenue Next Year
- GLPG $0.44
- MODG $1.60
- P/E Ratio
- GLPG N/A
- MODG N/A
- Revenue Growth
- GLPG 10.31
- MODG N/A
- 52 Week Low
- GLPG $22.36
- MODG $5.42
- 52 Week High
- GLPG $37.78
- MODG $11.60
- Technical
- Relative Strength Index (RSI)
- GLPG 41.14
- MODG 44.52
- Support Level
- GLPG $30.17
- MODG $10.31
- Resistance Level
- GLPG $33.12
- MODG $11.60
- Average True Range (ATR)
- GLPG 0.75
- MODG 0.60
- MACD
- GLPG -0.04
- MODG 0.00
- Stochastic Oscillator
- GLPG 22.55
- MODG 23.53
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.
About MODG Topgolf Callaway Brands Corp.
Topgolf Callaway Brands Corp is a modern golf and active lifestyle company that provides world-class golf entertainment experiences, designs and manufactures premium golf equipment, and sells golf and active lifestyle apparel and other accessories through brands such as, Topgolf, Callaway Golf, Odyssey, TravisMathew, Jack Wolfskin, OGIO and Toptracer. The company's reportable segments are; Topgolf, Golf Equipment and Active Lifestyle. Majority of the revenue is generated from its Topgolf segment which is predominantly comprised of service revenues and expenses from the company operated Topgolf venues, Toptracer ball-flight tracking technology, and WGT digital golf game. Geographically, majority of the revenue for the company is derived from United States.